Dominant type III hyperlipoproteinaemia (familial dysbetalipoproteinaemia)

Netherlands Journal of Medicine

Volumn 71, Issue 1, 2013, Pages 50-

  Stalenhoef, A F H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E2; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN;

DOMINANT GENE; GENE MUTATION; HUMAN; HYPERLIPOPROTEINEMIA TYPE 3; KRINGLE DOMAIN; LETTER; MUTATION;

HUMANS; HYPERLIPOPROTEINEMIA TYPE III; MUTATION;

EID: 84874141362     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Visser ME, Dallinga-Thie GM, Pinto-Sietsma SJ, Defesche JC, Stroes ES, van der Valk V. APOE1 mutation in a patient with type III hyperlipoproteinaemia: detailed genetic analysis required. Neth J Med. 2012;70:278-80.
2. de Knijff P, van den Maagdenberg AM, Stalenhoef AF, et al. Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree 1. J Clin Invest. 1991;88:643-55.
3. Utermann G. Genetic architecture and evolution of the lipoprotein(a) trait. Curr Opin Lipidol. 1999;10:133-41.
4. Marcovina SM, Albers JJ, Gabel B, Koschinsky ML, Gaur VP. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin Chem. 1995;41:246-55.
5. Menys VC, Liu Y, Mackness MI, Caslake MJ, Kwok S, Durrington PN. Measurement of plasma small-dense LDL concentration by a simplified ultracentrifugation procedure and immunoassay of apolipoprotein B. Clin Chim Acta. 2003;334:95-106.
6. Henneman P, van der Sman-de Beer, Moghaddam PH, et al. The expression of type III hyperlipoproteinemia: involvement of lipolysis genes. Eur J Hum Genet. 2009;17:620-8.